There was no statistically significant difference in hepcidin levels between patients with anemia (n = 20), (38.25 ± 16.2) and those without anemia (n = 62) (36.7 ± 14.6) in the IPF patient group (p = 0.702) (Table 2). This evidence concerns the gene HAMP and anemia.